SYVIPRONCT07503821
Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis
StatusRecruiting
PhaseNot applicable
SponsorNantes University Hospital
Primary completion (estimated)
At risk: Primary completion moved at least 6 months later across 2 updates.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 10 words
- Primary and study completion pushed from Sep 2030 to Oct 30, 2030
- Start date changed from estimate of Sep 2026 to Oct 30, 2026
- Secondary endpoints: details revised at 1 of 4 entries
Notable Recruitment openedv2 Show 4 more changesShow less
- Start date: Apr 2026 to Sep 2026
- Eligibility criteria shortened, about 1 word
- Primary and study completion pushed from Apr 2030 to Sep 2030
- Site details revised at 3 of 3 sites
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
number of samples
Timeframe: 1 day
Secondary (4)
Tissue quality
number of adverse events
Patient acceptability
Cluster analysis of results from high-throughput experiments
Arms and interventions
Synovial samplingExperimental
Synovial sampling on first visit
Procedures: synovial biopsy
Sites
3 sites in 1 country